Follow the 고려제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 고려제약 has published 13 insider filings. The latest transaction was disclosed on 25 February 2026 (Other). Among the most active insiders: 박해룡. Every trade is free.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.